Conflicts of interest and pandemic flu

@article{Godlee2010ConflictsOI,
  title={Conflicts of interest and pandemic flu},
  author={Fiona Godlee},
  journal={BMJ : British Medical Journal},
  year={2010},
  volume={340}
}
  • F. Godlee
  • Published 2010
  • Medicine
  • BMJ : British Medical Journal
WHO must act now to restore its credibility, and Europe should legislate 
What happened in Mexico
Another important issue for the World Health Organization’s declaration of the AH1N1 pandemic1 is how the original outbreak was managed in Mexico. After the outbreak was initially denied, a state ofExpand
Challenges on the interaction of models and policy for pandemic control
The COVID-19 pandemic has seen infectious disease modelling at the forefront of government decision-making. Models have been widely used throughout the pandemic to estimate pathogen spread andExpand
Pandemics: spend on surveillance, not prediction
Trust is undermined when scientists make overblown promises about disease prevention, warn Edward C. Holmes, Andrew Rambaut and Kristian G. Andersen.Trust is undermined when scientists make overblownExpand
H1N1 – the social costs of élite confusion
In May 2011, the World Health Assembly will receive the report of its International Health Regulations Review Committee examining responses to the outbreak of the 2009 H1N1 pandemic influenza andExpand
The sponsored pandemic of the Mexican flu?
The first reports of the New Influenza A (H1N1) spoke of a markedly increased morbidity and mortality. Later it turned out that this flu was a very mild flu. Gradually the role of the WHO wasExpand
WHO Director-General replies to the BMJ
  • M. Chan
  • Computer Science, Medicine
  • BMJ : British Medical Journal
  • 2010
TLDR
It is “almost certainly true” that the mildness of the H1N1 pandemic, compared with the severity long expected from a virus like H5N1, has contributed to the current critical scrutiny of WHO’s decisions, but this reality does not make it wrong to ask hard questions. Expand
The odium of industry engagement
  • S. Chapman
  • Business, Medicine
  • BMJ : British Medical Journal
  • 2010
TLDR
Widespread disengagement with vaccine producers would be like dietitians refusing to have anything to do with the food industry, which supplies almost all of the vaccine producers' products. Expand
The swine flu scam?
  • M. Evans
  • Medicine
  • Journal of public health
  • 2010
TLDR
‘This was a pandemic that never really was’ according to Paul Flynn, MP who prepared a recent report on the flu pandemic, which criticizes the proportionality of the response and argues that over reaction led to waste of public money, distortion of public health priorities and unjustified fears about health risks. Expand
NEW ETHICAL CHALLENGES OF DISEASES IN THE GLOBALIZATION AGE
The appearance and worldwide circulation in the past few years of some new infectious (pathogenic) agents (such as coronaviruses, SARS) or other more virulent variants of already known virusesExpand
Le retour de la conception biomédicale du paludisme dans les institutions internationales
We argue here that efforts against malaria are in line with a biomedical conception of the disease, which departs from the comprehensive and positive definition of health established at Alma-Ata inExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
WHO and the pandemic flu “conspiracies”
Key scientists advising the World Health Organization on planning for an influenza pandemic had done paid work for pharmaceutical firms that stood to gain from the guidance they were preparing. TheseExpand
Continuing the multiple sclerosis risk sharing scheme is unjustified
Christopher McCabe and colleagues examine the claims behind the decision not to reduce drug costs in the multiple sclerosis risk sharing scheme
Multiple sclerosis risk sharing scheme: a costly failure
  • J. Raftery
  • Medicine
  • BMJ : British Medical Journal
  • 2010
TLDR
The NHS is paying for thousands of patients with multiple sclerosis to receive drugs that monitoring data suggest are not effective, so what went wrong with the access scheme that facilitated their use is examined. Expand
The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution
TLDR
Tension remains between the competing goals of optimizing guideline quality by using the experience and insight of experts and ensuring that financial and intellectual conflicts of interest do not influence recommendations, so a strategy comprising 3 innovative aspects to address this tension is developed. Expand
Guidelines on guidelines
  • J. Townend
  • Medicine, Political Science
  • The Lancet
  • 2007
TLDR
As international researchers explore ways to better incorporate social research into their plans for biomedical prevention and treatment, they are invited to also consider the challenges faced by resourcepoor countries in supporting and conducting social and behavioural research. Expand
WHO in retreat: is it losing its influence?
TLDR
This article maps the changes in WHO's approach over the past 46 years and considers whether fears about its loss of influence are justified. Expand
Conflict of Interest in Medical Research, Education, and Practice
Collaborations of physicians and researchers with industry can provide valuable benefits to society, particularly in the translation of basic scientific discoveries to new therapies and products.Expand
WHO faces up to its tobacco links
  • F. Godlee
  • Medicine
  • BMJ : British Medical Journal
  • 2000
TLDR
Five years ago I wrote a critique of the World Health Organization in the BMJ and one of my sources was a report by an American economist, Richard Tollison, which tore apart the WHO's budgetary priorities, but didn't say that Tollison was in the pay of British American Tobacco. Expand
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
TLDR
Evidence is provided supporting the emerging view that treatment in multiple sclerosis must be given early in the course, before the consequences of inflammation are irretrievably established, and the formulation that inflammation and demyelination are responsible for relapses of multiple sclerosis is supported. Expand
We want raw data, now
  • F. Godlee
  • Medicine
  • BMJ : British Medical Journal
  • 2009
TLDR
It is concluded that the evidence that oseltamivir reduces complications in otherwise healthy people with pandemic influenza is now uncertain and that the authors need a radical change in the rules on access to trial data. Expand
...
1
2
...